1 |
Pfaff-Kilgore JM, Davidson E, Kadash-Edmondson K, Hernandez M, Rosenberg E, Chambers R, Castelli M, Clementi N, Mancini N, Bailey JR, Crowe JE Jr, Law M, Doranz BJ. Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening. Cell Rep 2022;39:110859. [PMID: 35613596 DOI: 10.1016/j.celrep.2022.110859] [Reference Citation Analysis]
|
2 |
Bonsignori M, Marcotrigiano J. HCV neutralization goes elite. Immunity 2022;55:195-7. [PMID: 35139349 DOI: 10.1016/j.immuni.2022.01.010] [Reference Citation Analysis]
|
3 |
Fu J, Qin W, Tong Q, Li Z, Shao Y, Liu Z, Liu C, Wang Z, Xu X. A novel DNA methylation-driver gene signature for long-term survival prediction of hepatitis-positive hepatocellular carcinoma patients. Cancer Med 2022. [PMID: 35637633 DOI: 10.1002/cam4.4838] [Reference Citation Analysis]
|
4 |
Goodsell DS, Burley SK. RCSB Protein Data Bank resources for structure-facilitated design of mRNA vaccines for existing and emerging viral pathogens. Structure 2021:S0969-2126(21)00376-2. [PMID: 34739839 DOI: 10.1016/j.str.2021.10.008] [Reference Citation Analysis]
|